Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Net Margin (2018 - 2025)

Historic Net Margin for Lipocine (LPCN) over the last 8 years, with Q3 2025 value amounting to 2781.46%.

  • Lipocine's Net Margin changed N/A to 2781.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 126.75%, marking a year-over-year decrease of 711200.0%. This contributed to the annual value of 0.08% for FY2024, which is 5809800.0% up from last year.
  • Latest data reveals that Lipocine reported Net Margin of 2781.46% as of Q3 2025.
  • Over the past 5 years, Lipocine's Net Margin peaked at 4883.19% during Q1 2021, and registered a low of 7216.68% during Q1 2023.
  • Moreover, its 5-year median value for Net Margin was 354.13% (2025), whereas its average is 1229.9%.
  • Its Net Margin has fluctuated over the past 5 years, first surged by 72633300bps in 2024, then tumbled by -20334400bps in 2025.
  • Quarter analysis of 5 years shows Lipocine's Net Margin stood at 78.48% in 2021, then plummeted by -771bps to 526.36% in 2022, then skyrocketed by 302bps to 1061.4% in 2023, then plummeted by -95bps to 50.94% in 2024, then plummeted by -5560bps to 2781.46% in 2025.
  • Its last three reported values are 2781.46% in Q3 2025, 354.13% for Q2 2025, and 1986.78% during Q1 2025.